Improving Smoking Cessation Interventions among People Living with HIV

Event Type:
Webinar
Date:
November 6, 2018

Webinar

Event Materials

Event Series

Funding Opportunity Announcement

These funding announcements have been reissued as RFA-CA-20-035 (R01 Clinical Trial Optional) and RFA-CA-20-036 (R21 Clinical Trial Optional).

This webinar provided an overview of the new Request for Applications (RFA) Improving Smoking Cessation Interventions among People Living with HIV RFA-CA-18-027 (R01 Clinical Trial Optional) and RFA-CA-18-028 (R21 Clinical Trial Optional).

These RFAs aim to improve cigarette smoking cessation treatment among people living with HIV (PLWH) in the United States. They will support research to systematically test existing evidence-based smoking cessation interventions and/or to develop and test adaptations of evidence-based smoking cessation interventions for application to PLWH.

Speaker

Annette Kaufman, Ph.D., M.P.H.
Annette Kaufman, Ph.D., M.P.H.

Program Director,
Tobacco Control Research Branch,
Behavioral Research Program,
National Cancer Institute (NCI)

Moderator

Michele Bloch, M.D., Ph.D.

Chief, Tobacco Control Research Branch, Behavioral Research Program, NCI

Technical Expert

Rick Berzon, DrPH., P.A.

Program Director, National Institute on Minority Health and Health Disparities

Last Updated
March 16, 2022